22 results
8-K
EX-99.1
XLO
Xilio Therapeutics Inc
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
and scientific leadership are in building successful companies across all stages of development and a broad range of therapeutic areas. On behalf of Xilio … with a deep leadership team, and I am grateful to René for her mentorship, encouragement and support in preparing me to pursue a CEO opportunity. Having
8-K
EX-99.1
6lxui8h4hojn
9 Aug 22
Results of Operations and Financial Condition
7:36am
8-K
EX-99.2
3qni2ja9do6 3wxbpd
12 May 22
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
7:36am
DEF 14A
zdxlyiuh
26 Apr 22
Definitive proxy
4:05pm
10-K
i83dirw oh
1 Mar 22
Annual report
4:07pm
8-K
EX-99.1
hpdj5x aekv6bt8sxe
6 Jan 22
Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
7:45am
10-Q
pakp1wh2m r3
2 Dec 21
Quarterly report
4:15pm
424B4
ddo0jb r8
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
rh2lo1bc
18 Oct 21
IPO registration (amended)
6:04am
S-1
rrvwqq ckl
1 Oct 21
IPO registration
4:49pm